How CAR T Cell Therapy Eliminated a Patient's Rare Blood Disease and Restored Her Strength скачать в хорошем качестве

How CAR T Cell Therapy Eliminated a Patient's Rare Blood Disease and Restored Her Strength

For 20+ years, Maureen lived with light chain (AL) amyloidosis, a rare and relentless blood disease. Then came a scientific breakthrough years in the making. Maureen enrolled in a CAR T cell clinical trial, led by Dr. Heather Landau, a bone marrow transplant specialist at Memorial Sloan Kettering Cancer Center (MSK). The trial was powered by a remarkable feat of scientific engineering developed in the lab called CAR T therapy. It removes a patient’s immune cells, re-programs them to attack the disease, and multiplies an army of these new cancer fighters to be put back into the body. Just one week after Maureen’s infusion of supercharged CAR T cells, her blood markers were all normal and she felt great. "We’re trying to take the same thing that Maureen benefited from and bring it to everybody,” says Dr. Karlo Perica, part of an MSK team redefining how cancer is treated. Subscribe and watch more in our special YouTube series Saved by Science to witness the emotional meetings between patients and the scientists who are transforming complex research into hope. 🧬 Read more about this research: https://bit.ly/4k4KPmX Request an appointment at MSK by calling 844-955-1758 or online at: https://bit.ly/3MvaRTJ CONNECT WITH MSK o Facebook:   / memorialsloankettering   o X: https://x.com/mskcancercenter o Instagram:   / memorialsloankettering   o LinkedIn:   / memorial-sloan-kettering-cancer-center